LONA
LeonaBio, Inc.
$8.87
+0.49 (+5.85%)
At close · Jul 2
Market Cap
$83.32M
Shares
9,393,514
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-06-23 | JOHNSON JAMES A |
Director | Award | 28,000 |
| 2026-06-23 | PICKERING GRANT |
Director, CHIEF EXECUTIVE OFFICER | Award | 28,000 |
| 2026-06-23 | EDELMAN JOSEPH |
Director | Award | 28,000 |
| 2026-06-23 | Kosacz Barbara |
Director | Award | 28,000 |
| 2026-06-23 | Panzara Michael A. |
Director | Award | 28,000 |
| 2026-06-23 | Romano Kelly A |
Director | Award | 28,000 |
| 2026-06-23 | Silverman Peter B. |
Director | Award | 2,333 |
| 2026-06-23 | Holles Natalie C. |
Director | Award | 2,333 |
| 2026-06-23 | Callori Fred |
Director | Award | 2,333 |
| 2026-05-05 | Silverman Peter B. |
Director | Award | 56,000 |
| 2026-05-05 | Callori Fred |
Director | Award | 56,000 |
| 2026-05-05 | Silverman Peter B. |
Director | Other | 0 |
| 2026-05-05 | Callori Fred |
Director | Other | 0 |
| 2026-05-05 | Holles Natalie C. |
Director | Award | 56,000 |
| 2026-05-05 | Holles Natalie C. |
Director | Other | 0 |
| 2026-04-09 | Litton Mark James |
Director, PRESIDENT and CEO | Award | 750,000 |
| 2026-04-09 | San Martin Javier |
CHIEF MEDICAL OFFICER | Award | 350,000 |
| 2026-04-09 | EDELMAN JOSEPH |
Director | Award | 28,000 |
| 2026-04-09 | JOHNSON JAMES A |
Director | Award | 28,000 |
| 2026-04-09 | FLUKE JOHN M JR |
Director | Award | 28,000 |
| 2026-04-09 | CHURCH KEVIN |
CHIEF SCIENTIFIC OFFICER | Award | 300,000 |
| 2026-04-09 | Kosacz Barbara |
Director | Award | 28,000 |
| 2026-04-09 | Panzara Michael A. |
Director | Award | 28,000 |
| 2026-04-09 | Worthington Mark |
GENERAL COUNSEL and CCO | Award | 300,000 |
| 2026-04-09 | Renninger Robert |
CHIEF FINANCIAL OFFICER | Award | 300,000 |
| 2026-04-09 | PICKERING GRANT |
Director, CHIEF EXECUTIVE OFFICER | Award | 28,000 |
| 2026-04-09 | Romano Kelly A |
Director | Award | 28,000 |
| 2026-03-04 | Litton Mark James |
Director, PRESIDENT and CEO | Sell | 5,156 |
| 2026-03-04 | San Martin Javier |
CHIEF MEDICAL OFFICER | Sell | 1,720 |
| 2026-03-04 | Worthington Mark |
GENERAL COUNSEL and CCO | Sell | 1,328 |
| 2026-03-04 | CHURCH KEVIN |
CHIEF SCIENTIFIC OFFICER | Sell | 1,359 |
| 2026-03-04 | Renninger Robert |
CHIEF FINANCIAL OFFICER | Sell | 906 |
| 2026-03-03 | Renninger Robert |
CHIEF FINANCIAL OFFICER | Convert | 3,900 |
| 2026-03-03 | San Martin Javier |
CHIEF MEDICAL OFFICER | Convert | 7,418 |
| 2026-03-03 | CHURCH KEVIN |
CHIEF SCIENTIFIC OFFICER | Convert | 5,856 |
| 2026-03-03 | Worthington Mark |
GENERAL COUNSEL and CCO | Convert | 5,726 |
| 2026-03-03 | Litton Mark James |
Director, PRESIDENT and CEO | Convert | 22,254 |
| 2026-03-03 | San Martin Javier |
CHIEF MEDICAL OFFICER | Convert | 7,418 |
| 2026-03-03 | Worthington Mark |
GENERAL COUNSEL and CCO | Convert | 5,726 |
| 2026-03-03 | Litton Mark James |
Director, PRESIDENT and CEO | Convert | 22,254 |
| 2026-03-03 | CHURCH KEVIN |
CHIEF SCIENTIFIC OFFICER | Convert | 5,856 |
| 2026-03-03 | Renninger Robert |
CHIEF FINANCIAL OFFICER | Convert | 3,900 |
| 2026-01-02 | Renninger Robert |
CHIEF FINANCIAL OFFICER | Sell | 297 |
| 2026-01-02 | CHURCH KEVIN |
CHIEF SCIENTIFIC OFFICER | Sell | 876 |
| 2026-01-02 | Litton Mark James |
Director, PRESIDENT and CEO | Sell | 2,586 |
| 2026-01-02 | San Martin Javier |
CHIEF MEDICAL OFFICER | Sell | 1,644 |
| 2026-01-02 | Worthington Mark |
GENERAL COUNSEL and CCO | Sell | 876 |
| 2025-12-31 | CHURCH KEVIN |
CHIEF SCIENTIFIC OFFICER | Convert | 3,667 |
| 2025-12-31 | CHURCH KEVIN |
CHIEF SCIENTIFIC OFFICER | Convert | 3,667 |
| 2025-12-31 | Litton Mark James |
Director, PRESIDENT and CEO | Convert | 10,834 |
Showing 1–50 of 327 transactions